Altice USA, Inc.
Altice USA, Inc. (ATUS) Financial Performance & Income Statement Overview
Analyze Altice USA, Inc. (ATUS) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Altice USA, Inc. (ATUS) Income Statement & Financial Overview
Analyze Altice USA, Inc.’s ATUS earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q2 2025 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $2.15B | $2.24B | $2.24B | $2.23B |
| Cost of Revenue | $670.53M | $721.89M | $721.89M | $711.33M |
| Gross Profit | $1.48B | $1.51B | $1.51B | $1.52B |
| Gross Profit Ratio | $0.69 | $0.68 | $0.68 | $0.68 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $1.14B | $1.17B | $1.17B | $1.07B |
| Total Costs & Expenses | $1.81B | $1.89B | $1.89B | $1.78B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $428.02M | $434.90M | $434.90M | $448.17M |
| Depreciation & Amortization | $418.49M | $471.73M | $471.73M | $386.34M |
| EBITDA | -$69.24M | $814.27M | $814.27M | $783.78M |
| EBITDA Ratio | -$0.03 | $0.36 | $0.36 | $0.35 |
| Operating Income | $343.46M | $340.76M | $340.76M | $444.59M |
| Operating Income Ratio | $0.16 | $0.15 | $0.15 | $0.20 |
| Other Income/Expenses (Net) | -$430.69M | -$433.13M | -$433.13M | -$495.32M |
| Income Before Tax | -$87.23M | -$92.36M | -$92.36M | -$50.73M |
| Income Before Tax Ratio | -$0.04 | -$0.04 | -$0.04 | -$0.02 |
| Income Tax Expense | -$15.96M | -$46.12M | -$46.12M | -$9.89M |
| Net Income | -$75.68M | -$54.12M | -$54.12M | -$42.97M |
| Net Income Ratio | -$0.04 | -$0.02 | -$0.02 | -$0.02 |
| EPS | -$0.16 | -$0.12 | -$0.12 | -$0.09 |
| Diluted EPS | -$0.16 | -$0.12 | -$0.12 | -$0.09 |
| Weighted Avg Shares Outstanding | $464.86M | $461.54M | $461.54M | $460.63M |
| Weighted Avg Shares Outstanding (Diluted) | $464.86M | $461.54M | $461.54M | $460.63M |
Financial performance has remained strong, with revenue growing from $2.23B in Q3 2024 to $2.24B in Q2 2025. Gross profit continued to perform well, with margins at 68% in the latest quarter. Operating income reached $340.76M in Q2 2025, holding a steady 15% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $814.27M. Net income rose to -$54.12M, keeping EPS at -$0.12. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan